Monica Tang is a Rheumatology/Immunology physician affiliated with City College of San Francisco. OpenAlex indexes 52 publications with 1,039 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
400 Parnassus Ave
San Francisco, CA 941432202
Telephone
415-353-2725Provider last certified this registry record 14 Feb 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20242 payments
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
- GENZYME CORPORATIONProgram year20237 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
92.2%Corticosteroid43%Trelegy Ellipta51%Symbicort20%Dulera16%Budesonide-Formoterol Fumarate14%Part D<11 patientsHistamine-1 Receptor Antagonist26.3%Azelastine Hcl68%Azelastine-Fluticasone32%Part D<11 patients+ 2 more classes in this area
Dermatology
7.8%Interleukin-4 Receptor alpha Antagonist7.8%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma
American Journal of Respiratory and Critical Care Medicine
2025 - High airway thymic stromal lymphopoietin in asthma is associated with type 2 inflammation, mucus plugging, and airway remodeling
Journal of Allergy and Clinical Immunology
2025 - Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis
International Forum of Allergy & Rhinology
2025 - Response to the Editor Regarding: “In Office Sampling of Eosinophil Peroxidase to Diagnose Eosinophilic Chronic Rhinosinusitis”
International Forum of Allergy & Rhinology
2025 - Variations in the Blood Eosinophil to Serum IgE (eos/IgE) Ratio Identify Asthma Subgroups With Distinct Clinical Traits
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sima Porten, MD
City College of San Francisco
Nalin Gupta, MD
City College of San Francisco
Trever Bivona, MD, PhD
City College of San Francisco
Ethan Winkler, MD, PhD
City College of San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”